Nick Reading

Nick Reading has a diverse work experience spanning various industries. Nick is currently working as the Global Product Owner (Director) at Vectura Group since November 2019. Prior to that, they had a substantial career at Novartis from 2016 to 2019, holding roles such as Global Brand Lead and Program Manager, Divestment Implementations. Before joining Novartis, Nick worked as a University Lecturer at Duale Hochschule Baden Württemberg (DHBW) Karlsruhe from 2014 to 2016. Nick also served as a Project Manager at Kliniken des Landkreises Lörrach GmbH from December 2014 to February 2016.

Nick's earlier work experience includes roles such as General Manager at Birmingham Women's Hospital from 2009 to 2014, Directorate Manager at Heart of England NHS Foundation Trust from March 2009 to November 2009, and Business Manager for Community Health Services at Coventry & Warwickshire Partnership Trust from July 2007 to February 2009. Nick began their career as a Graduate Management Trainee at NHS Leadership Academy, where they completed three placements over a two-year period.

In addition to their healthcare experience, Nick also gained financial expertise as an Investment Manager at Hathaway Investment Management Ltd. from January 2003 to May 2005. In this role, they assisted the senior team with financial analysis, investment and client reviews, and compliance and regulatory work.

Overall, Nick Reading has a progressive work history with experience in global product management, brand leadership, program management, healthcare management, lecturing, project management, financial analysis, and investment management.

Nick Reading has a Bachelor of Commerce (B.Com.) degree in Accounting and Finance from the University of Birmingham, which they obtained from 1999 to 2002. Nick later pursued a Master of Science (MSc) in Healthcare Management and Leadership at the same university, completing it from 2005 to 2007. In 2012 and 2013, they participated in the Aspiring Senior Leaders Programme at Hult Ashridge. Nick also completed a Postgraduate Program - Certificate of Advanced Studies (CAS) in Clinical Trial Practice and Management at the University of Basel in 2016. Additionally, they obtained a certification in Product Strategy from Kellogg Executive Education in June 2022.